ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Journal

publication venue for

A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance 2024
Persistence Dynamics of Antimicrobial-Resistant Neisseria in the Pharynx of Rhesus Macaques. 64. 2020
Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers. 62. 2018
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a MethionyltRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study. 61. 2017
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients. 60:6252-6259. 2016
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients. 60:6252-6259. 2016
Frequent Use of Chlorhexidine-Based Body Wash Associated with a Reduction in Methicillin-Resistant Staphylococcus aureus Nasal Colonization among Military Trainees. 59:943-949. 2015
Prevalence of Chlorhexidine-Resistant Methicillin-Resistant Staphylococcus aureus following Prolonged Exposure. 58:4404-4410. 2014
Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network. 58:4035-4041. 2014
Zafirlukast Inhibits Complexation of Lsr2 with DNA and Growth of Mycobacterium tuberculosis. 57:2134-2140. 2013
Novel Pentadecenyl Tetrazole Enhances Susceptibility of Methicillin-ResistantStaphylococcus aureusBiofilms to Gentamicin. 55:3691-3695. 2011
Correlation of Antimicrobial Resistance with β-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City. 52:2999-3005. 2008
Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm. 51:1804-1812. 2007
Modeling the Combination of Amphotericin B, Micafungin, and Nikkomycin Z against Aspergillus fumigatus In Vitro Using a Novel Response Surface Paradigm. 51:1804-1812. 2007
Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial. 51:3591-3598. 2007
Geographic Distribution of a Large Mobile Element That Transfers Ampicillin and Vancomycin Resistance between Enterococcus faecium Strains. 44:1349-1351. 2000
Evaluation of Several Dosing Regimens of Cefepime, with Various Simulations of Renal Function, against Clinical Isolates of Pseudomonas aeruginosa in a Pharmacodynamic Infection Model. 43:129-133. 1999
Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus , Coagulase-Negative Staphylococci, Enterococcus faecalis , and Enterococcus faecium. 42:721-724. 1998
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model. 40:1148-1152. 1996
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. 40:677-683. 1996
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. 40:691-695. 1996
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model. 39:1797-1801. 1995
Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia. 31:1328-1331. 1987
Efficacy of Macrolides and Telithromycin against Leptospirosis in a Hamster Model 2006

category

MICROBIOLOGY Category
PHARMACOLOGY & PHARMACY Category

International Standard Serial Number (ISSN)

0066-4804

Electronic International Standard Serial Number (EISSN)

1098-6596

journal abbreviation

ANTIMICROB AGENTS CH